Exelixis Inc (NAS:EXEL)
$ 35.81 -0.04 (-0.11%) Market Cap: 10.23 Bil Enterprise Value: 9.24 Bil PE Ratio: 22.96 PB Ratio: 4.50 GF Score: 91/100

Exelixis Inc Corporate R&D Day Transcript

Dec 12, 2023 / 02:00PM GMT
Release Date Price: $22.77 (+3.27%)
Operator

Good morning. Please welcome Michael Morrissey.

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

All right, welcome, everybody. Thanks for joining us today at our R&D Day, where we're going to focus on science and strategy of building the Exelixis pipeline of the future. I want to thank everybody for joining us today here in New York. I want to welcome everybody joining us online as well. It should be a good couple of hours.

Before I start, before we start, I want to thank the team front row. We've spent the last month or so prepping for this. So I want to thank everybody for their efforts in refining the slides and the messaging and everything else has been a real team effort. I want to shout out to various board members who are here today. Thanks for your support and interest in coming here today as well. I want to welcome and acknowledge Dr. Monty Pal, from City of Hope. He's our long-time colleague and collaborator with cabo and zanza. He's at least today entered a really folk hero status at Exelixis. He was in the clinic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot